Home > Healthcare > Medical Services > Lab Services > Egg Freezing and Embryo Banking Market

Egg Freezing and Embryo Banking Market – By Service Type, By Storage Duration, By Technology, By Application, By Age Group - Global Forecast, 2024 – 2032

  • Report ID: GMI11172
  • Published Date: Oct 2024
  • Report Format: PDF

Egg Freezing and Embryo Banking Market Size

The global egg freezing and embryo banking market size was valued at around USD 4.3 billion in 2023 and is estimated to grow at 9.8% CAGR from 2024 to 2032. The market refers to the global sector dedicated to services and technologies that facilitate the cryopreservation (freezing) of oocytes (egg cells) and embryos for future use.
 

Egg Freezing and Embryo Banking Market

Driven by technological advancements in cryopreservation, automation, and artificial intelligence (AI), the egg freezing, and embryo banking market is witnessing rapid expansion. Innovations such as enhanced vitrification methods and AI-driven embryo selection are boosting the success rates of fertility preservation. Additionally, government backing for fertility preservation initiatives and reproductive technologies, coupled with research funding for issues including infertility and reproductive aging, is further accelerating the market's momentum.
 

Moreover, startups are leading this transformation by introducing innovative cryogenic storage solutions and improving access to fertility preservation services through digital platforms and telehealth consultations. Growing societal awareness about fertility preservation, along with more robust regulatory frameworks and advances in telemedicine, is increasing the demand for egg freezing and embryo banking services. This trend aligns with broader healthcare movements emphasizing patient-centric care and equitable access, thereby promoting industry expansion.
 

Further, collaborations between technology and healthcare sectors, with a focus on data security and patient privacy, are driving the future of the egg freezing and embryo banking market. The shift toward preventive healthcare is enhancing women's control over reproductive choices, offering personalized treatment plans and real-time monitoring. By addressing unmet reproductive health needs and expanding access to secure, innovative solutions, the market shows strong growth potential in the coming years.
 

Egg Freezing and Embryo Banking Market Trends

  • The markets are poised for substantial growth, driven by shifting social, technological, and medical dynamics. With an increasing number of women choosing to postpone childbearing for career, educational, or personal reasons, the demand for fertility preservation services is surging.
     
  • Additionally, medical reasons are also driving the adoption of fertility preservation. Women undergoing treatments such as chemotherapy, which pose risks to reproductive health, are increasingly turning to these services. Awareness of fertility preservation options is expanding, and so is the appetite for both egg freezing and embryo banking. For instance, as per Statista, breast cancer was the most prevalent cancer type among females in 2022 with around 48 women living with this type of cancer per 100,000 population worldwide.
     
  • Technological strides, particularly in cryopreservation, play a pivotal role in this growth. Enhanced vitrification methods have significantly boosted the success rates of freezing and thawing eggs and embryos, resulting in superior preservation outcomes and heightened chances of successful pregnancies.
     
  • In tandem, AI-driven embryo selection is proving to be an invaluable asset, refining the process of identifying viable embryos for IVF treatments. Research indicates that AI-assisted embryo selection can elevate implantation rates by up to 30%, streamlining and enhancing the overall process. Furthermore, the incorporation of genomic and proteomic testing amplifies the quality of embryos earmarked for banking, thereby bolstering the odds of favorable outcomes.
     
  • Beyond medical imperatives, egg freezing is gaining traction for non-medical, lifestyle-oriented reasons. A growing number of women are opting for social egg freezing, allowing them to focus on their careers or personal pursuits without compromising their fertility.
     
  • This phenomenon is especially pronounced in urban centers, where professional women are increasingly deferring motherhood. Recognizing this trend, major corporations are integrating eggfreezing benefits into their employee health packages, thereby normalizing and championing the cause of fertility preservation. Such corporate endorsements are pivotal in driving adoption in this domain.
     

Egg Freezing and Embryo Banking Market Analysis

Egg Freezing and Embryo Banking Market, By Service Type, 2021 – 2032 (USD Billion)

Based on service type, the egg freezing and embryo banking market is divided into egg freezing and embryo banking. The embryo banking segment is expected to witness a CAGR of 9.7% during the forecast period.
 

  • Embryo banking is a crucial facet of the market, involving the cryopreservation of embryos created through in-vitro-fertilization (IVF) which is estimated to reach USD 32.9 billion by 2032, for future use. This practice has gained prominence due to rising infertility rates and changing societal norms that prioritize delayed childbearing. By preserving embryos at a younger age, individuals and couples can enhance their chances of successful pregnancies, particularly for those facing medical conditions that affect fertility.
     
  • Moreover, technological advancements, such as improved cryopreservation techniques such as vitrification, have significantly increased embryo viability and success rates upon thawing.
     
  • Thus, embryo banking offers a valuable option for individuals seeking to secure their reproductive futures, aligning with the growing demand for effective fertility preservation solutions.
     
Egg Freezing and Embryo Banking Market, By Storage Duration (2023)

Based on storage duration, the egg freezing and embryo banking market is bifurcated into short-term storage and long-term storage. In 2023, the short-term storage segment held a substantial share of 67.2%.
 

  • Short-term storage in egg freezing and embryo banking allows for the temporary preservation of frozen eggs or embryos, typically for a duration of a few months to a few years. Individuals or couples often choose this option with the intention of soon utilizing the preserved eggs or embryos in assisted reproductive technology procedures, particularly in vitro fertilization (IVF).
     
  • This storage solution provides flexibility for patients undergoing fertility treatments, medical procedures like chemotherapy, or those delaying pregnancy for personal or professional reasons. Clinics and fertility centers employ advanced cryopreservation techniques, such as vitrification, to ensure optimal storage conditions, thereby maintaining the viability and quality of the eggs or embryos.
     
  • This short-term approach empowers individuals to navigate their reproductive plans without a long-term commitment, contributing to the growing demand for fertility preservation services.
     

Based on technology, the egg freezing and embryo banking market is bifurcated into vitrification and slow freezing. The vitrification segment is growing robustly, with a 9.9% CAGR during the forecast period.
 

  • Vitrification plays a pivotal role in egg freezing and embryo banking. By rapidly cooling reproductive cells, vitrification prevents the ice crystal formation that can harm cell structures. In contrast to traditional slow-freezing methods, vitrification swiftly converts the egg or embryo into a glass-like solid. This quick transformation results in enhanced survival rates during both the freezing and thawing processes.
     
  • The introduction of vitrification has revolutionized fertility preservation, markedly increasing the viability of eggs and embryos. This heightened viability translates to improved success rates in assisted reproductive technologies (ART), including in vitro fertilization (IVF).
     

Based on application, the egg freezing and embryo banking market is bifurcated into fertility preservation, donor egg/embryo programs, genetic screening, and oncofertility. The fertility preservation segment accounted for a share of 30.9% in 2023 and is expected to grow at a CAGR of 9.7% during the forecast period.
 

  • Fertility preservation enables women to freeze and store their eggs or embryos for future use. This option offers flexibility for those delaying pregnancy due to personal, professional, or medical reasons, such as chemotherapy treatments that may affect fertility. The process starts with hormonal stimulation for egg retrieval, followed by advanced cryopreservation techniques, especially vitrification, to ensure the long-term viability of the eggs or embryos.
     
  • Further, awareness is increasing about fertility challenges related to aging, lifestyle choices, and medical conditions, leading more women to choose fertility preservation. This proactive step not only secures their reproductive potential but also provides greater control over family planning. These decisions align with broader trends in reproductive autonomy and personalized healthcare, stimulating the growth of the market in today's reproductive medicine landscape.
     

Based on age group, the egg freezing and embryo banking market is bifurcated into under 30, 31 to 40, and over 41. The 31 to 40 segment accounted for a share of 45.6% in 2023.
 

  • The age group of 31 to 40 years plays a crucial role in egg freezing and embryo banking, as many women in this demographic are actively pursuing career advancements, education, and personal development, often postponing childbearing until later in life. This postponement can lead to challenges related to fertility, as the quality and quantity of oocytes gradually decline with age. Egg freezing serves as a proactive solution, enabling women to preserve their oocytes while they are still at a higher quality, thus enhancing their chances of successful conception in the future.
     
  • Additionally, embryo banking allows couples to create and store embryos for later use, providing flexibility in family planning. With the availability of advanced reproductive technologies and genetic screening, women aged 31 to 40 can make informed decisions regarding their reproductive health, significantly improving their prospects for healthy pregnancies and reducing the risks of genetic disorders.
     
  • Therefore, This age group represents a growing segment in the fertility market, stimulated by increasing awareness and acceptance of fertility preservation options.
     
U.S. Egg Freezing and Embryo Banking Market, 2021 – 2032 (USD Billion)

The U.S. accounted for a 1.7 billion revenue in 2023 and is expected to experience substantial growth reaching USD 3.8 billion by 2032.
 

  • The U.S. egg freezing and embryo banking market is set for substantial growth, driven by increased awareness of fertility preservation and technological advancements. This growth is supported by the region's advanced healthcare infrastructure, featuring state-of-the-art medical facilities and highly trained professionals, ensuring top-notch quality and accessibility in egg freezing and embryo banking services.
     

The egg freezing and embryo banking market in UK is expected to experience significant and promising growth of 10.3% from 2024 to 2032.
 

  • Technological advancements in cryopreservation are playing a pivotal role in the growth of the market in the UK. The development of improved vitrification techniques has significantly enhanced the survival rates of frozen eggs and embryos, increasing confidence among individuals and couples considering fertility preservation.
     
  • Additionally, recent breakthroughs now allow for longer and safer storage durations without compromising the viability or quality of the preserved gametes and embryos. These innovations, coupled with the UK's extended storage limit of up to 55 years, are making fertility preservation more accessible and appealing, encouraging broader adoption of these services across diverse demographic groups.
     

Japan accounted for largest share of 29.3% in the Asia Pacific egg freezing and embryo banking market is anticipated to witness lucrative growth between 2024 – 2032.
 

  • In Japan, the demand for egg freezing and embryo banking is increasing among single individuals and same-sex couples as evolving cultural attitudes create more acceptance of alternative family structures. Many individuals are opting for fertility preservation to keep the option of having biological children open for the future.
     
  • Additionally, the growing use of IVF and surrogacy services is further driving demand for egg and embryo banking, as these services complement assisted reproductive technologies. With greater awareness and acceptance of non-traditional parenting, fertility preservation is becoming a viable and attractive option for diverse demographic groups in Japan.
     

The egg freezing and embryo banking market in Saudi Arabia is expected to growth with a CAGR of 9.1% from 2024 to 2032.
 

  • In Saudi Arabia, growing awareness and educational campaigns are playing a crucial role in driving the adoption of egg freezing and embryo banking services. Healthcare providers and fertility clinics are actively conducting outreach programs to educate individuals about the benefits of fertility preservation, empowering them to make informed reproductive choices.
     
  • Additionally, increased media coverage on fertility and reproductive health is helping to normalize these discussions, encouraging more people to explore egg freezing and embryo banking as viable options. This heightened awareness is fostering greater acceptance of fertility preservation across different demographics, contributing to the market's steady growth.
     

Egg Freezing and Embryo Banking Market Share

The market features a competitive landscape with major global players and small to medium-sized firms vying for market share. A key strategy centers on the continuous development of innovative cryopreservation techniques to improve success rates and ensure specimen viability. Leading companies drive advancements through substantial investments in research and development focused on refining freezing methods, enhancing storage solutions, and improving patient outcomes. Strategic alliances, partnerships, and collaborations play a crucial role in strengthening market positions and expanding global reach, especially in response to evolving medical standards, growing awareness of fertility preservation, and rising demand for accessible reproductive solutions.
 

Egg Freezing and Embryo Banking Market Companies

Some of the eminent market participants operating in the egg freezing and embryo banking industry include:

  • Boston IVF
  • Carrot
  • CCRM Fertility
  • Cryos International
  • Extend Fertility
  • Genea Pty
  • IVIRMA
  • Monash IVF Group
  • New Hope IVF & Fertility Clinic
  • Ovation Fertility
  • Progyny
  • ReproTech
  • RMA Network
  • Shady Grove Fertility
  • Spring Fertility
  • WINFertility
     

Egg Freezing and Embryo Banking Industry News:

  • In November 2023, Spanish investment firm GED Capital and fertility group IVIRMA Global acquired the Barcelona-based fertility business Eugin Group in a deal valued at up to €500 million (USD 558.4 million), including earn-outs. This acquisition enabled IVIRMA Global to further its expansion into the North American market.
     
  • In June 2021, Boston IVF, a fertility clinic with over 25 locations across the U.S., announced a partnership with TMRW Life Sciences, Inc. to introduce innovative technology and automation to its cryostorage and fertility cell management practices. This integration of TMRW's groundbreaking innovations exemplifies Boston IVF's ongoing leadership in reproductive medicine. The partnership is expected to enhance operational efficiency, improve the accuracy of cryopreservation processes, and further solidify the clinic's position at the forefront of fertility treatment advancements.
     

The egg freezing and embryo banking market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Service Type

  • Egg freezing
  • Embryo banking

Market, By Storage Duration

  • Short-term storage
  • Long-term storage                       

Market, By Technology

  • Vitrification
  • Slow freezing

Market, By Application

  • Fertility preservation
  • Donor egg/embryo programs
  • Genetic screening
  • Oncofertility

Market, By Age Group

  • Under 30 
  • 31 to 40
  • Over 41                  

The above information is provided for the following regions and countries:

  • North America 
    • U.S.
    • Canada
  • Europe 
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific 
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America 
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa 
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global egg freezing and embryo banking industry was valued at approximately USD 4.3 billion in 2023 and is estimated to grow at a 9.8% CAGR from 2024 to 2032, driven by advancements in cryopreservation technologies.

The embryo banking segment is expected to witness a CAGR of 9.7% during the forecast period, fueled by rising infertility rates and changing societal norms that prioritize delayed childbearing.

The U.S. egg freezing and embryo banking industry was valued at USD 1.7 billion in 2023 and is projected to reach USD 3.8 billion by 2032, driven by increased awareness of fertility preservation and technological advancements.

Who are some of the prominent players in the egg freezing and embryo banking industry? Key players in the industry include Boston IVF, Carrot, CCRM Fertility, Cryos International, Extend Fertility, Genea Pty, IVIRMA, Monash IVF Group, New Hope IVF & Fertility Clinic, and Ovation Fertility.

Egg Freezing and Embryo Banking Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 172
  • Countries covered: 20
  • Pages: 145
 Download Free Sample